Dmitry Kostyushev
Dmitry Kostyushev
National Medical Research Center for Tuberculosis and Infectious Diseases
Verified email at
Cited by
Cited by
Dead Cas systems: types, principles, and applications
S Brezgin, A Kostyusheva, D Kostyushev, V Chulanov
International journal of molecular sciences 20 (23), 6041, 2019
Введение в предиктивно-превентивную медицину: опыт прошлого и реалии дня завтрашнего
ТА Бодрова, ДС Костюшев, ЕН Антонова, ДА Гнатенко, МО Бочарова, ...
Вестник Российской академии медицинских наук 68 (1), 58-64, 2013
Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus
D Kostyushev, S Brezgin, A Kostyusheva, D Zarifyan, I Goptar, ...
Cellular and Molecular Life Sciences 76 (9), 1779-1794, 2019
Протеомика как фундаментальный инструмент доклинического скрининга, верификации анализов и оценки применяемой терапии
СВ Сучков, ДА Гнатенко, ДС Костюшев, СА Крынский, МА Пальцев
Вестник Российской академии медицинских наук 68 (1), 65-71, 2013
Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9
D Kostyushev, A Kostyusheva, S Brezgin, D Zarifyan, A Utkina, I Goptar, ...
Scientific reports 9 (1), 1-11, 2019
CRISPR-Cas systems for diagnosing infectious diseases
VC Anastasiya Kostyusheva, Sergey Brezgin , Yurii Babin, Irina Vasilyeva ...
Methods, 2021
Gene Editing by Extracellular Vesicles
VC Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, Valery Smirnov ...
International Journal of Molecular Sciences 21 (19), 7362, 2020
Introduction into PPPM as a new paradigm of public health service: an integrative view
TA Bodrova, DS Kostyushev, EN Antonova, S Slavin, DA Gnatenko, ...
EPMA Journal 3 (1), 1-11, 2012
Small molecular inhibitors of DNA double strand break repair pathways increase the ANTI-HBV activity of CRISPR/Cas9
AP Kostyusheva, DS Kostyushev, SA Brezgin, DN Zarifyan, EV Volchkova, ...
Molecular Biology 53 (2), 274-285, 2019
Clinical implications of hepatitis B virus RNA and covalently closed circular DNA in monitoring patients with chronic hepatitis B today with a gaze into the future: the field …
A Kostyusheva, D Kostyushev, S Brezgin, E Volchkova, V Chulanov
Genes 9 (10), 483, 2018
Overexpression of nitric oxide synthase restores circulating angiogenic cell function in patients with coronary artery disease: implications for autologous cell therapy for …
Q Chen, M Varga, X Wang, DJ Haddad, S An, L Medzikovic, ...
Journal of the American Heart Association 5 (1), e002257, 2016
Proteomics as a fundamental tool for subclinical screening, tests verification and assessment of applied therapy
SV Suchkov, DS Kostushev, SA Krynskii, DA Gnatenko, MA Pal'tsev
Annals of the Russian academy of medical sciences 68 (1), 65-71, 2013
HIV-1 reverse transcriptase promotes tumor growth and metastasis formation via ROS-dependent upregulation of twist
E Bayurova, J Jansons, D Skrastina, O Smirnova, D Mezale, ...
Oxidative medicine and cellular longevity 2019, 2019
Replenishment of hepatitis B virus cccDNA pool is restricted by baseline expression of host restriction factors in vitro
S Brezgin, A Kostyusheva, E Bayurova, I Gordeychuk, M Isaguliants, ...
Microorganisms 7 (11), 533, 2019
ATM and ATR expression potentiates HBV replication and contributes to reactivation of HBV infection upon DNA damage
A Kostyusheva, S Brezgin, E Bayurova, I Gordeychuk, M Isaguliants, ...
Viruses 11 (11), 997, 2019
Introduction into PPPM: experience of the past and tomorrow’s reality
TA Bodrova, DS Kostushev, EN Antonova, DA Gnatenko, MO Bocharova, ...
Annals of the Russian academy of medical sciences 68 (1), 58-64, 2013
Современный взгляд на проблему выбора вакцины против гепатита В
ВП Чуланов, ТА Семененко, ИВ Карандашова, СВ Комарова, ...
Эпидемиология и вакцинопрофилактика 16 (4 (95)), 65-72, 2017
Nanomedicine for increasing the oral bioavailability of cancer treatments
A Parodi, P Buzaeva, D Nigovora, A Baldin, D Kostyushev, V Chulanov, ...
Journal of Nanobiotechnology 19 (1), 1-19, 2021
Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
DS Kostyushev, AP Zueva, SA Brezgin, AD Lipatnikov, VN Simirskii, ...
Terapevticheskii arkhiv 89 (11), 21-26, 2017
A modern view of the problem of choosing a vaccine against hepatitis B
VP Chulanov, TA Semenenko, IV Karandashova, SV Komarova, ...
Epidemiology and vaccination 4 (95), 65-72, 2017
The system can't perform the operation now. Try again later.
Articles 1–20